Authors
Richard M. Sharpe
Title
Environment, lifestyle and male infertility
Journal
Bailliere's Clinical Endocrinology and Metabolism 14(3) 2000
Summary
The objective of this paper is to review some of the environmental and
lifestyle factors affecting sperm count and fertility. The extreme variation
in sperm count and ejaculate between individuals in the general population
has posed a constraint in studying the relationship between a particular
environmental factor, lifestyle or occupation and a reduced sperm count
and/or fertility in the human male. Due to this variation, a large number
of subjects would need to be studied, thus increasing costs and ruling
out many studies.
The enormous variation in sperm count among men is related to the number
of Sertoli cells in the testes. These unique cells control the development
of germ cells into spermatozoa. Each Sertoli cell supports a fixed number
of germ cells by providing an environment within the seminiferous tubules
in which germ cells develop and by providing a physical and nutritional
support for these cells. A simple linear relationship between Sertoli
cell number and daily sperm production has been established. However,
Sertoli cell number varied more than 50-fold among the men. The factors
involved in Sertoli cell number variation remains unknown; however,
the neonatal (0-9 months) and the peri-pubertal periods are the most
crucial times for Sertoli development. In this regard, early life events
are potentially important in determining male reproductive development
and function. In addition, genetic differences among men may also play
a role, as evidenced in studies of infertility and low sperm count in
brothers.
The organization of the stages of spermatogenesis in human males is
different from that of species with highly efficient spermatogenesis.
The poor efficiency ('efficiency' referring to the number of germ cells
that each Sertoli cell supports) of spermatogenesis in the human male
may make him more susceptible than other species to the adverse effects
of environmental factors. Under normal conditions, human males also
produce a high proportion (>50%) of morphologically abnormal sperm
incapable of fertilizing. Primates (i.e. chimpanzees) that have an organization
of spermatogenesis similar to that of the human also have a reduced
efficiency of spermatogenesis. Since it is not just man who exhibits
this phenomenon, it can be said that lifestyle and environmental factors
do not affect spermatogenesis efficiency.
A study conducted in Denmark compared the sperm count in two groups
of nearly 200 young men, one group from a rural and one from an urban
population. A higher median sperm count (24%) was found in men from
the rural group than in those from the urban group. In addition, blood
levels of follicle-stimulating hormone (FSH) and inhibin B (a hormone
influenced by alterations in Sertoli cell number) were also significantly
different in the two groups (the inhibin B level bein higher and the
FSH level lower in the group with the highest sperm count). Thus, a
well-designed study involving a large number of men and measuring a
combination of blood hormone and sperm count may be a more accurate
approach to establish the relationship between occupation/environment
and human testis function.
A significant relationship between scrotal temperature and sperm count
has been established in recent years. The sedentary lifestyle of men
of all ages may impair the ability of the scrotum to thermoregulate.
Men with more sedentary lifestyles or occupations have higher average
scrotal temperature. In turn, an elevation of scrotal temperature to
normal core body temperature results in a failure of spermatogenesis.
This effect is probably at its worst in paraplegic men. A study of normal
young men showed that an elevation of scrotal temperature by as little
as 0.7C for 75% of the working day was sufficient to significantly impair
semen quality. A rise in scrotal temperature may increase the number
of abnormal sperm, decrease sperm motility and/or decrease the number
of sperm in the ejaculate. These effects may lead to impaired fertility
and can affect implantation and early embryo development as the miscarriage
rate is significantly elevated in female animals after mating with an
"affected" male.
Events occurring during fetal and neonatal development of the testis
are believed to be critical in determining reproductive abnormalities,
including low sperm count and infertility. For example, testicular germ
cell cancer (approximately 90% of cases occurring in the age range of
15-45 years) originates from abnormal gonocytes in the testis that developed
in fetal life and activated to grow into a tumour post-pubertally. In
addition, developmental disorders of the reproductive system, such as
cryptorchidism and hypospadias, and factors such as low birth weight,
are important risk factors of testicular cancer. In this context, testicular
cancer is associated with reduced semen quality and reduced fertility,
both of which are evident long before tumour development. The neonatal
rather than fetal life may be more important as the period of most rapid
Sertoli cell proliferation in the first 6-9 months postnatally. Since
the number of Sertoli cells is so critical in determining sperm production,
it is possible that events in the first year of life will likely influence
sperm production in adulthood by affecting Sertoli cell proliferation.
The incidence of testicular cancer has increased significantly throughout
much of the world over the past 50-100 years century. This clearly suggests
that lifestyle and/or environmental factors are having a profound negative
effect on early male reproductive development. For example, a high level
of a range of pesticides is detectable in human adipose tissue. Lipid-soluble
pesticides accumulating in fat raises concerns regarding the transmission
of such compounds from the mother to the breast-feeding infant. Indeed,
the first-born infants of older mothers would be those most highly exposed
in this way. However, it is unknown whether this is a contributing factor
towards human reproductive development or function.
Given the central role that hormones play in guiding the development
of the reproductive system, it is not surprising that a major focus
of endocrine disruption research has been on reproductive health. Over
the last decade, a large number of hormonally active compounds have
been discovered. Not only are more compounds involved, but more hormone
systems are now known to be vulnerable and new mechanisms of interaction
between compounds and receptor systems have been explored to understand
the way(s) by which a compound exerts its effects. Until recently, research
has been focused on the oestrogenic activity of various chemicals in
plastics (i.e. phthalates), pesticides (i.e. DDT), products of combustion
(dioxins), polychlorinated biphenyls (PCBs) and many more. Most of these
compounds appear to be very weak oestrogens that it is unlikely that
they pose a significant risk to sperm count or fertility.
The nematocide dibromochloropropane (DBCP) is the only pesticide that
has been unequivocally shown to lead to a major decrease in sperm count
and infertility after human exposure. While this compound is still being
used in some developing countries it is important to note that its effects
on semen quality are not believed to be through an endocrine mechanism
but rather involves direct toxicity to the spermatogonia. Animal studies
have resulted in conflicting conclusions regarding the relationship
between endocrine disruptors and the incidence of testicular cancer
and decreased sperm production. However, it has recently been determined
that several phthalates are potent anti-androgens and thus of concern
considering the key role of androgens in male reproductive development.
A recent study has reported that PCBs, at a very low concentration,
can prolong the bio-activity of endogenously produced estrogens by inhibiting
oestrogen sulphotransferase, a key enzyme that inactivates oestrogens
in the body. Since the human male fetus develops in an environment consisting
of oestrogens, any changes in the production, action or metabolism of
endogenous hormones as a result of exogenous chemical exposure could
potentially alter endogenous oestrogen exposure by the fetus.